Cite
Capitanio S, Bongioanni F, Piccardo A, et al. Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions. World J Radiol. 2016;8(2):200-9doi: 10.4329/wjr.v8.i2.200.
Capitanio, S., Bongioanni, F., Piccardo, A., Campus, C., Gonella, R., Tixi, L., Naseri, M., Pennone, M., Altrinetti, V., Buschiazzo, A., Bossert, I., Fiz, F., Bruno, A., DeCensi, A., Sambuceti, G., & Morbelli, S. (2016). Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions. World journal of radiology, 8(2), 200-9. https://doi.org/10.4329/wjr.v8.i2.200
Capitanio, Selene, et al. "Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions." World journal of radiology vol. 8,2 (2016): 200-9. doi: https://doi.org/10.4329/wjr.v8.i2.200
Capitanio S, Bongioanni F, Piccardo A, Campus C, Gonella R, Tixi L, Naseri M, Pennone M, Altrinetti V, Buschiazzo A, Bossert I, Fiz F, Bruno A, DeCensi A, Sambuceti G, Morbelli S. Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions. World J Radiol. 2016 Feb 28;8(2):200-9. doi: 10.4329/wjr.v8.i2.200. PMID: 26981229; PMCID: PMC4770182.
Copy
Download .nbib